Results 191 to 200 of about 1,923,312 (279)
Nirsevimab for respiratory syncytial virus prevention: A comprehensive product review. [PDF]
Razzini JL, Martinon-Torres F.
europepmc +1 more source
Early-life respiratory syncytial virus infection and asthma. [PDF]
Tolentino J +4 more
europepmc +1 more source
ABSTRACT Introduction Human respiratory syncytial virus (HRSV) is a major cause of respiratory disease. It is classified into two antigenic subgroups. While several authors have studied the potential link between HRSV infection and later development of recurrent wheezing (RW) or asthma, no previous studies have assessed the role of HRSV subtypes.
María Arroyas Sánchez +7 more
wiley +1 more source
Infection risk in rheumatoid arthritis patients treated with biologic and targeted therapies
In this context, infections associated with each biologic and targeted drug are summarized to inform the stratification of RA patients, including the characteristics of the susceptible patients and their concomitant therapy. We aim to provide a benefit‐risk analysis for clinical decision, and vital indications for the prevention of highly correlated ...
Lujing Wang, Jieshi Lin, Jie Qian
wiley +1 more source
Identification of core differentially expressed genes for respiratory syncytial virus infection. [PDF]
Deng Q +7 more
europepmc +1 more source
Bovine Alphaherpesvirus 1 (BoHV‐1) and Bovine respiratory syncytial virus (BRSV) are major drivers of respiratory disease in cattle. (A) To target both pathogens, two chimeric antigens—membrane‐linked and secreted—combining BoHV‐1 glycoprotein D and BRSV fusion glycoprotein were designed and expressed using recombinant BoHV‐4‐based vectors.
Antonino Di Lorenzo +7 more
wiley +1 more source
Respiratory syncytial virus - from discovery to vaccines. [PDF]
López EL, Ferolla FM, Acosta PL.
europepmc +1 more source
ABSTRACT Background Laboratory‐based influenza surveillance in low‐ and middle‐income countries may have limited timeliness and geographic coverage. We evaluated whether over‐the‐counter (OTC) respiratory medication sales track seasonal influenza activity and provide early warning of influenza onset in South Africa.
Malebo Sephule Makunyane +5 more
wiley +1 more source
Long-acting monoclonal antibodies and the evolving landscape of infant respiratory syncytial virus prevention. [PDF]
Wang R, Abu-Raya B, Obeid H, Xie Z.
europepmc +1 more source
ABSTRACT Background In Kenya, influenza and other respiratory viruses circulate year‐round. The Ministry of Health monitors severe acute respiratory infections (SARI), including influenza‐associated hospitalizations, through a sentinel surveillance network. We developed intensity thresholds (ITs) to assess seasonal severity based on respiratory illness‐
Elizabeth B. White +11 more
wiley +1 more source

